Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04071119 · ClinicalTrials.gov registry record · Phase 1
Alcohol and Cigarette Craving During Oxytocin Treatment
A Phase 1 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT04071119 is a Phase 1 study that has completed, run by Brown University. The registered enrollment target is 19 participants.
The verdict
NCT04071119, a Phase 1 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
This proposed research seeks to examine the behavioral and neural substrates of intranasal oxytocin compared to placebo on alcohol cue-induced alcohol and cigarette craving smokers with an alcohol use disorder (AUD). Non treatment-seeking smokers with an AUD will be recruited to participate in a between-subjects, placebo-controlled, randomized pilot functional magnetic resonance imaging (fMRI) study. Participants will undergo an fMRI scan in conjunction with an alcohol-olfactory cue-reactivity task. Secondary assessments will include alcohol and cigarette craving, alcohol and cigarette consumption, physiological measures (heart rate and blood pressure) and mood measures.
Interventions
- DRUG Placebo
- DRUG Oxytocin nasal spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2024-04-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04071119
The ClinicalTrials.gov registry entry for NCT04071119 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04071119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04071119 about?
NCT04071119 is a clinical study titled "Alcohol and Cigarette Craving During Oxytocin Treatment". This proposed research seeks to examine the behavioral and neural substrates of intranasal oxytocin compared to placebo on alcohol cue-induced alcohol and cigarette craving smokers with an alcohol use disorder (AUD). Non treatment-seeking smokers with an AUD will be recruited to participate in a bet...
What is the current status of trial NCT04071119?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2020-11-09. Estimated completion is 2024-04-02.
What interventions are being tested in trial NCT04071119?
The interventions under investigation include: Placebo (DRUG), Oxytocin nasal spray (DRUG).
Who is sponsoring clinical trial NCT04071119?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.